157 related articles for article (PubMed ID: 37795066)
21. Vildagliptin-insulin combination improves glycemic control in Asians with type 2 diabetes.
Kozlovski P; Foley J; Shao Q; Lukashevich V; Kothny W
World J Diabetes; 2013 Aug; 4(4):151-6. PubMed ID: 23961326
[TBL] [Abstract][Full Text] [Related]
22. Vildagliptin: clinical trials programme in monotherapy and combination therapy for type 2 diabetes.
Rosenstock J; Fitchet M
Int J Clin Pract Suppl; 2008 Mar; (159):15-23. PubMed ID: 18269437
[TBL] [Abstract][Full Text] [Related]
23. Efficacy and Safety of Vildagliptin as Add-on to Metformin in Japanese Patients with Type 2 Diabetes Mellitus.
Odawara M; Hamada I; Suzuki M
Diabetes Ther; 2014 Jun; 5(1):169-81. PubMed ID: 24604395
[TBL] [Abstract][Full Text] [Related]
24. Efficacy and Safety of Vildagliptin as an Add-on to Insulin with or without Metformin in Japanese Patients with Type 2 Diabetes Mellitus: A 12-week, Double-Blind, Randomized Study.
Hirose T; Suzuki M; Tsumiyama I
Diabetes Ther; 2015 Dec; 6(4):559-571. PubMed ID: 26620049
[TBL] [Abstract][Full Text] [Related]
25. Comparison of the Efficacy, Tolerability and Side Effect Profile of Vildagliptin-Metformin with Metformin-GlibenclamideMamong Nigerian.
Uloko AT; Salawu OA; Uloko AE; Gezawa ID
West Afr J Med; 2021 Aug; 38(8):756-761. PubMed ID: 34503324
[TBL] [Abstract][Full Text] [Related]
26. Glucose-lowering agents for treating pre-existing and new-onset diabetes in kidney transplant recipients.
Lo C; Jun M; Badve SV; Pilmore H; White SL; Hawley C; Cass A; Perkovic V; Zoungas S
Cochrane Database Syst Rev; 2017 Feb; 2(2):CD009966. PubMed ID: 28238223
[TBL] [Abstract][Full Text] [Related]
27. Effectiveness and Tolerability of Vildagliptin and the Single Pill Combination of Vildagliptin and Metformin in "Real-World" Management of Type 2 Diabetes Mellitus: The G-FORCE Study.
Van Gaal L; Hermans MP; Daci E; Denhaerynck K; De Meester L; MacDonald K; Abraham I; Vancayzeele S; Maris M
Diabetes Ther; 2019 Jun; 10(3):965-979. PubMed ID: 30919316
[TBL] [Abstract][Full Text] [Related]
28. Comparison of dipeptidyl peptidase-4 inhibitors and pioglitazone combination therapy versus pioglitazone monotherapy in type 2 diabetes: A system review and meta-analysis.
Wang B; Sun Y; Sang Y; Liu X; Liang J
Medicine (Baltimore); 2018 Nov; 97(46):e12633. PubMed ID: 30431561
[TBL] [Abstract][Full Text] [Related]
29. Metabolic effects of pioglitazone and rosiglitazone in patients with diabetes and metabolic syndrome treated with glimepiride: a twelve-month, multicenter, double-blind, randomized, controlled, parallel-group trial.
Derosa G; Cicero AF; Gaddi A; Ragonesi PD; Fogari E; Bertone G; Ciccarelli L; Piccinni MN
Clin Ther; 2004 May; 26(5):744-54. PubMed ID: 15220018
[TBL] [Abstract][Full Text] [Related]
30. Pioglitazone hydrochloride in combination with metformin in the treatment of type 2 diabetes mellitus: a randomized, placebo-controlled study. The Pioglitazone 027 Study Group.
Einhorn D; Rendell M; Rosenzweig J; Egan JW; Mathisen AL; Schneider RL
Clin Ther; 2000 Dec; 22(12):1395-409. PubMed ID: 11192132
[TBL] [Abstract][Full Text] [Related]
31. Effects of Vildagliptin or Pioglitazone on Glycemic Variability and Oxidative Stress in Patients with Type 2 Diabetes Inadequately Controlled with Metformin Monotherapy: A 16-Week, Randomised, Open Label, Pilot Study.
Kim NH; Kim DL; Kim KJ; Kim NH; Choi KM; Baik SH; Kim SG
Endocrinol Metab (Seoul); 2017 Jun; 32(2):241-247. PubMed ID: 28685513
[TBL] [Abstract][Full Text] [Related]
32. Efficacy and safety of vildagliptin, Saxagliptin or Sitagliptin as add-on therapy in Chinese patients with type 2 diabetes inadequately controlled with dual combination of traditional oral hypoglycemic agents.
Li CJ; Liu XJ; Bai L; Yu Q; Zhang QM; Yu P; Yu DM
Diabetol Metab Syndr; 2014; 6():69. PubMed ID: 24917890
[TBL] [Abstract][Full Text] [Related]
33. Efficacy and Safety of Remogliflozin Etabonate, a New Sodium Glucose Co-Transporter-2 Inhibitor, in Patients with Type 2 Diabetes Mellitus: A 24-Week, Randomized, Double-Blind, Active-Controlled Trial.
Dharmalingam M; Aravind SR; Thacker H; Paramesh S; Mohan B; Chawla M; Asirvatham A; Goyal R; Shembalkar J; Balamurugan R; Kadam P; Alva H; Kodgule R; Tandon M; Vaidyanathan S; Pendse A; Gaikwad R; Katare S; Suryawanshi S; Barkate H
Drugs; 2020 Apr; 80(6):587-600. PubMed ID: 32162274
[TBL] [Abstract][Full Text] [Related]
34. Efficacy and safety profile of sitagliptin, vildagliptin, and metformin in newly diagnosed type 2 diabetic subjects.
Elhini SH; Hussien AK; Omran AAE; Elsayed AA; Saeed H
Clin Exp Pharmacol Physiol; 2021 Dec; 48(12):1589-1602. PubMed ID: 34333803
[TBL] [Abstract][Full Text] [Related]
35. Effects of one year treatment of vildagliptin added to pioglitazone or glimepiride in poorly controlled type 2 diabetic patients.
Derosa G; Maffioli P; Ferrari I; Mereu R; Ragonesi PD; Querci F; Franzetti IG; Gadaleta G; Ciccarelli L; Piccinni MN; D'Angelo A; Salvadeo SA
Horm Metab Res; 2010 Aug; 42(9):663-9. PubMed ID: 20560108
[TBL] [Abstract][Full Text] [Related]
36. Evaluation of pharmacokinetic and pharmacodynamic interaction between the dipeptidyl peptidase IV inhibitor vildagliptin, glyburide and pioglitazone in patients with Type 2 diabetes.
Serra D; He YL; Bullock J; Riviere GJ; Balez S; Schwartz S; Wang Y; Ligueros-Saylan M; Jarugula V; Dole WP
Int J Clin Pharmacol Ther; 2008 Jul; 46(7):349-64. PubMed ID: 18793589
[TBL] [Abstract][Full Text] [Related]
37. Vildagliptin: a review of its use in type 2 diabetes mellitus.
Keating GM
Drugs; 2010 Nov; 70(16):2089-112. PubMed ID: 20964454
[TBL] [Abstract][Full Text] [Related]
38. Comparison of vildagliptin-metformin and glimepiride-metformin treatments in type 2 diabetic patients.
Jeon HJ; Oh TK
Diabetes Metab J; 2011 Oct; 35(5):529-35. PubMed ID: 22111045
[TBL] [Abstract][Full Text] [Related]
39. Efficacy of different antidiabetic drugs based on metformin in the treatment of type 2 diabetes mellitus: A network meta-analysis involving eight eligible randomized-controlled trials.
Peng Y; Chen SH; Liu XN; Sun QY
J Cell Physiol; 2019 Mar; 234(3):2795-2806. PubMed ID: 30145806
[TBL] [Abstract][Full Text] [Related]
40. Comparison of vildagliptin as an add-on therapy and sulfonylurea dose-increasing therapy in patients with inadequately controlled type 2 diabetes using metformin and sulfonylurea (VISUAL study): A randomized trial.
Hong AR; Lee J; Ku EJ; Hwangbo Y; Kim KM; Moon JH; Choi SH; Jang HC; Lim S
Diabetes Res Clin Pract; 2015 Jul; 109(1):141-8. PubMed ID: 26003889
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
